Human platelet lysates (HPL), isolated from human mesenchymal stem cells, are serving an excellent alternative to fetal bovine serum (FBS). The replacement of FBS helps in the prevention of bovine prion and viral contamination, and can also represent a new therapeutic challenge in the field of stem cell therapy, increasing the demand of human platelet lysates. The evolution of human platelet lysates has boosted various experimental and clinical research studies. Human platelet lysates do not affect functional capacities. Alternatives to FBS are human blood-derived components, namely, plasma, serum, umbilical cord blood serum, and platelet derivatives such as platelet lysates. Multiple applications of human platelet lysates, such as research, development, and production of biotechnology and pharmaceutical drug therapies, is expected to increase the growth of human platelet lysate market.
Increasing Government Funding to Boost Human Platelet Lysate Market Growth
Increasing government funding for life science-related projects, and rising number of research centers and research institutes, are factors driving the growth of the human platelet lysate market. In 2013, around 59% of total research & development expenditure in the U.S. was from federal funding agencies. In 2016, 12% of federal stem cell research funding was allocated to human embryonic stem cell research.
Collaboration - Strategic Focus for Lucrative Growth Opportunities
To maximize research output, research institutes and biotech companies are collaborating for clinical trials and other research projects. Cambium Medical Technologies LLC collaborated with Massachusetts Eye and Ear Infirmary, Oregon Health and Science University, University of Michigan, and Duke University for a clinical trial of topical fibrinogen-depleted human platelet lysates in patients with dry eye secondary to graft vs. host disease.
Increasing Demand for Biopharmaceuticals to Propel Human Platelet Lysate Market
With increasing incidence of several virus- or bacteria-borne infections and diseases, the scope of biopharmaceuticals is also increasing. Monoclonal antibody (MAb) therapeutics is amongst the most dynamic and promising pipelines in the biopharmaceutical market. Above 200 biopharmaceutical products are marketed and many more are in the development phase. Various biopharmaceutical products such as cancer vaccines, RNA interference, stem cells, cultured tissue transplants, and genes are going to be great assets for public health over the coming years.
A comprehensive perspective of the human platelet lysate market has led our analysts to infer that, the market is growing at a decent rate, with North America, followed by Europe, holding a large share in the global human platelet lysate market, attributable to well-developed research centers in these regions. Increasing research & developmental activities have led to the adoption of human platelet lysates in developed countries of North America and Europe. New product launches are anticipated to create more opportunities for players in the global human platelet lysate market.
Human Platelet Lysate Market - Scope of the Report
Persistence Market Research (PMR) recently published a market report on the global human platelet lysate market. The report provides detailed assessment on key market dynamics, including the drivers, trends, opportunities restraints, and detailed information about the human platelet lysate market structure. PMR’s report presents exclusive information about how the human platelet lysate market is expected to grow during the forecast period of 2019-2029.
Key indicators of market growth, which include Year-on-Year (Y-o-Y) growth of the market, and compounded annual growth rate (CAGR) are explained in PMR’s study in a comprehensive manner. This information can help readers understand the quantitative growth prospects of the human platelet lysate market during the forecast period.
The study is relevant for stakeholders in the human platelet lysate market, including human platelet lysate therapy manufacturers, suppliers, distributors, and investors, and can help them to develop effective strategies to grow in the market. Stakeholders in the human platelet lysate market, investors, industry experts, researchers, and journalists, as well as business researchers can leverage the information and data presented in PMR’s study.
The study also includes statistics as well as facts related to macro- as well as micro-economic factors that are impacting developments in the market. It also offers actionable insights based on the future trends in the human platelet lysate market. Furthermore, small businesses and new entrants in the human platelet lysate market can make use of the information presented in this study to make efficient business decisions to gain momentum in the market.
Key Segments of Human platelet lysate Market
PMR’s study on the human platelet lysate market offers information divided into four important segments - product type, application, end user, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.
Key Questions Answered in PMR’s Human Platelet Lysate Market Report
Human Platelet Lysate Market: Research Methodology
In PMR’s study, a unique research methodology is utilized to conduct extensive research on the growth of the human platelet lysate market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure accuracy and reliability of the conclusions in this report.
Secondary resources referred to by analysts during production of the human platelet lysate market study include statistics from government organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.
Comprehensive information acquired from primary resources and secondary resources acts as a validation from companies in the human platelet lysate market, and makes PMR’s projection on the growth prospects of the human platelet lysate market more accurate and reliable.